1. Home
  2. AII vs TECX Comparison

AII vs TECX Comparison

Compare AII & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AII

American Integrity Insurance Group Inc.

N/A

Current Price

$18.50

Market Cap

357.1M

Sector

Finance

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$29.70

Market Cap

545.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AII
TECX
Founded
2006
2019
Country
United States
United States
Employees
313
60
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
357.1M
545.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AII
TECX
Price
$18.50
$29.70
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$26.33
$75.20
AVG Volume (30 Days)
95.7K
172.8K
Earning Date
02-24-2026
05-07-2026
Dividend Yield
5.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.92
N/A
Revenue Next Year
$17.74
N/A
P/E Ratio
$4.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.78
$14.39
52 Week High
$26.36
$35.99

Technical Indicators

Market Signals
Indicator
AII
TECX
Relative Strength Index (RSI) 46.65 53.41
Support Level $17.58 $28.31
Resistance Level $19.46 $32.27
Average True Range (ATR) 0.57 1.48
MACD -0.05 -0.27
Stochastic Oscillator 31.05 50.39

Price Performance

Historical Comparison
AII
TECX

About AII American Integrity Insurance Group Inc.

American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, North Carolina, South Carolina, and Georgia.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: